Navigation Links
Catholic Health Association Applauds HHS Decision on Plan B
Date:12/9/2011

WASHINGTON, Dec. 9, 2011 /PRNewswire-USNewswire/ -- Sister Carol Keehan, DC, president and chief executive officer of the Catholic Health Association of the United States (CHA), issued the following statement.

The Catholic Health Association is very grateful to HHS Secretary Kathleen Sebelius for her intelligent and courageous decision to prevent very young adolescents from purchasing and administering unsupervised the strong hormone contained in the drug known as Plan B.

There is grave concern about the safety of very young adolescents self-administering this hormone at such a critical time in their growth cycle. This is not a case of politics versus science. There is no strong science that definitively establishes the safety of this drug when self-administered by 11- and 13-year olds. 

CHA has great respect for the FDA, but there are no significant studies in 11 to 13-year olds over a long period of time that have demonstrated the safety of this very significant drug. We do not want to learn in 10 to 20 years about this drug what we now know about hormone replacement therapy and its connection to breast cancer. In addition, there are no long term studies that demonstrate the drug's potential impact on future reproductive choices these young girls will make.

Our country must help parents exercise their responsibility to their children. Giving parents control over relatively inconsequential areas such as ear-piercing and then taking it away in such a serious area would not only put their children at risk but undermine parents' ability to parent. This great country is built on the strength of the family and this decision helps to maintain a strong role for parents in critical decisions. 

The Catholic Health Association of the United States (CHA), founded in 1915, supports the Catholic health ministry's commitment to improve the health status of communities and create quality and compassionate health care that works for everyone. The Catholic health ministry is the nation's largest group of not-for-profit health systems and facilities that, along with their sponsoring organizations, employ more than 750,000 women and men who deliver services combining advanced technology with the Catholic caring tradition. For more information, visit the CHA website at www.chausa.org.


'/>"/>
SOURCE Catholic Health Association of the United States
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Receives Purchase Orders from Catholic Health Initiatives for its MammoView(TM) Product Line
2. Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement
3. HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools
5. OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
6. IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
7. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
8. Genomic Health Announces Positive Results of First Clinical Outcomes Study for Biomarker Discovery Using Next Generation Sequencing at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
9. Nicotinic Acid: The Key Ingredient in Niacin Dietary Supplements that Supports Heart Health
10. Verinata Health Announces New Corporate Headquarters and Expanded Laboratory Operations
11. Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 ... clinical-stage oncology drug development company, announces that it ... Drug Administration (FDA) authorizing the initiation a Phase ... treatment for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) ... (RIT). MabVax plans to initiate the phase I ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
(Date:2/23/2017)... 2017 This report analyzes analyzes the worldwide markets for ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... Gevir, a New ... antler velvet, announced its products are coming soon to Amazon.com, the world’s largest online ... Thomson as a means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... treatment to the thousands of individuals who have recently fallen victim to America’s opioid ... in Orange County, California, where they are free from the shame, stigma, and ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes customized ... room, fewer hospital admissions, and better blood pressure and glycemic control, a ... study can be found here . , The study comes as health ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
Breaking Medicine News(10 mins):